Stockreport

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

CytoMed Therapeutics Limited - Ordinary Shares  (GDTC) 
PDF SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical c [Read more]